Atar, Dan

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 8,943

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal

Atrial Fibrillation Management and OutcomesClinical practice guidelines implementation

Cited by 6,418

The Effects of Climate Change on Cardiac Health

De Blois, J., Kjellstrom, T., Agewall, S., Ezekowitz, J. A., Armstrong, P. W., & Atar, D. (2015) · Cardiology

Climate Change and Health ImpactsThermoregulation and physiological responses

Cited by 1,697

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery

Atrial Fibrillation Management and OutcomesClinical practice guidelines implementation

Cited by 1,403

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 1,132

Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction

Mentz, R. J., Kelly, J. P., von Lueder, T. G., Voors, A. A., Lam, C. S. P., Cowie, M. R., Kjeldsen, K., Jankowska, E. A., Atar, D., Butler, J., et al. (2014) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 546

Long-term evolocumab in patients with established atherosclerotic cardiovascular disease

O’Donoghue, M. L., Giugliano, R. P., Wiviott, S. D., Atar, D., Keech, A., Kuder, J. F., Im, K., Murphy, S. A., Flores-Arredondo, J. H., López, J. A. G., et al. (2022) · Circulation

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 410

Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction

Labugger, R., Organ, L., Collier, C., Atar, D., & Van Eyk, J. E. (2000) · Circulation

Acute Myocardial Infarction ResearchClinical Laboratory Practices and Quality Control

Cited by 315

NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study

Provan, S., Angel, K., Semb, A. G., Atar, D., & Kvien, T. K. (2010) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesHeart Failure Treatment and Management

Cited by 50

Health Care Professionals’ Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey

Aamodt, I. T., Lycholip, E., Celutkiene, J., Strömberg, A., Atar, D., Falk, R. S., von Lueder, T., Hellesø, R., Jaarsma, T., & Lie, I. (2019) · Journal of Medical Internet Research

Telemedicine and Telehealth ImplementationHeart Failure Treatment and Management

Cited by 49

No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab

Korthauer, L. E., Giugliano, R. P., Guo, J., Sabatine, M. S., Sever, P., Keech, A., Atar, D., Kurtz, C., Ruff, C. T., Mach, F., et al. (2022) · PLOS ONE

Lipoproteins and Cardiovascular HealthAlzheimer's disease research and treatments

Cited by 11